Sort by
Refine Your Search
-
Category
-
Employer
- Institute of Photonic Sciences
- CIC bioGUNE
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Fundación IMDEA Nanociencia
- Basque Center for Macromolecular Design and Engineering POLYMAT Fundazioa
- CIC bioGUNE (Asociación Centro de Investigación Cooperativa en Biociencias)
- Center for Advanced Smart Materials (CASM), Yongjiang Laboratory (Y-Lab)
- Corify Care
- Fundación para la gestión de la investigación Biomédica de Cádiz
- IDAEA-CSIC
- Institute of Agrochemistry and Food Technology (IATA-CSIC)
- Institute of Cosmos Sciences of University of Barcelona
- 2 more »
- « less
-
Field
-
. The selected candidate will develop a computational platform to identify hierarchical combinations of cell fate conversion factors, which will in turn be used to engineer highly specialized neuronal subtypes
-
González Caballero. Project in Charge: Fondos Hemodinámica. Internal Reference: ACOTECHEM26. Where to apply Website https://inibica.es/inscripcion_acotechem26/ Requirements Research FieldAllEducation
-
should identify an ICFO research group of interest, review the corresponding research lines, and submit a brief outline of a proposed research project. Share this opening! Use the following URL: https
-
Center for Advanced Smart Materials (CASM), Yongjiang Laboratory (Y-Lab) | Spain | about 6 hours ago
science and transformative technology. At its heart is the Center for Advanced Smart Materials (CASM), a flagship 7,000 m² research facility designed for full-chain innovation: from discovery-level
-
Website https://www.idaea.csic.es/ Street Jordi Girona, 18-26 Postal Code 08034 STATUS: EXPIRED X (formerly Twitter) Facebook LinkedIn Whatsapp More share options E-mail Pocket Viadeo Gmail Weibo Blogger
-
support. Share this opening! Use the following URL: https://jobs.icfo.eu/?detail=1085
-
CIC bioGUNE (Asociación Centro de Investigación Cooperativa en Biociencias) | Bilbao, Pais Vasco | Spain | 3 months ago
to engineer highly specialized neuronal subtypes for cell transplantation therapies in animal models of Alzheimer's disease, stroke, and epilepsy. To achieve this goal, the candidate will combine a gene network